FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W937952246> ?p ?o ?g. }

• W937952246 endingPage "500" @default.
• W937952246 startingPage "493" @default.
• W937952246 abstract "Caracterizar pacientes com artrite reumatoide (AR) quanto à presença de fatores de risco para doenças cardiovasculares. Estudo transversal descritivo com 71 pacientes diagnosticados com AR definida. Foram usados os instrumentos: DAS‐28, HAQ e SF‐36 e determinados os parâmetros: velocidade de hemossedimentação, glicemia capilar, colesterol total (CT) e suas frações, hormônios tiroidianos, anticorpos antinúcleo (ANA), fator reumatoide (FR) e anticorpos contra proteínas citrulinadas (ACPAs). Os pacientes foram classificados em grupos HAQ ≤ 1 (disfunção leve) e HAQ > 1 (disfunção moderada e grave) e, segundo os escores do HAQ, em grupo tratado com corticosteroides (CE) e sem CE. Proporção de nove homens para 62 mulheres com idade e tempo médio de doença de 53,45 (± 10,7) e 9,9 (± 8,6), respectivamente. O FR foi positivo em 52 (76%), os ACPAs em 54 (76,1%) e o ANA em 12 (16,9%). Trinta e seis pacientes (50,7%) apresentaram hipertensão arterial sistêmica, nove (12,68%) diabetes mellitus, 16 (22,5%) hipotireoidismo, 33 (46,5%) dislipidemia e oito (11,27%) tabagismo. O grupo HAQ > 1 (26) apresentou resultados de CT > 240 (53,8%) e o grupo com HAQ ≤ 1 (45) (24,4%) (p = 0,020). Os grupos não diferiram quanto à presença de comorbidades ou tratamento farmacológico. Os níveis de triglicérides > 200 (42,4%) entre os grupos em uso de CE e sem uso (18,42%) foi significativo (p = 0,025). Houve associação do aumento CT e triglicerídeos com resultados de HAQ ≤ 1 e com uso de CE, o que reforça a importância do rastreamento de fatores de risco associados às doenças cardiovasculares na AR. To identify risk factors for cardiovascular disease in patients with Rheumatoid Arthritis (RA). A descriptive cross‐sectional study with 71 patients with established RA. The instruments used were: DAS‐28, HAQ and SF‐36, and the following parameters were determined: the erythrocyte sedimentation rate, capillary blood glucose; total cholesterol (TC) and its fractions, thyroid hormones, antinuclear antibodies (ANA), rheumatoid factor (RF) and antibodies against citrullinated proteins (ACPAs). Patients were classified into groups HAQ ≤ 1 (mild dysfunction) and HAQ > 1 (moderate and severe dysfunction) and, according to the HAQ scores, in groups treated with corticosteroids (CS) and without CS. 9 patients were male and 62 female with mean age and duration of disease of 53.45 (± 10.7) and 9.9 (± 8.6), respectively. RF was positive in 52 (76%), ACPAs in 54 (76.1%) and ANA in 12 (16.9%). Thirty‐six patients (50.7%) had systemic hypertension, 9 (12.68%) diabetes mellitus, 16 (22.5%) hypothyroidism, 33 (46.5%) dyslipidemia and 8 (11.27%) were smokers. The results of TC >240 were found in 53.8% for group HAQ >1 (26) and in 24.4% for group HAQ ≤ 1 (45) (p = 0.020). These groups did not differ as to presence of comorbidities or drug treatment. Triglyceride levels >200 for the group with CS (42.4%) versus without CS (18.42%) were significant (p = 0.025). An association of increased TC and triglycerides with results of HAQ ≤ 1 and with CS use was noted, reinforcing the importance of screening risk factors associated with cardiovascular disease in RA." @default.
• W937952246 created "2016-06-24" @default.
• W937952246 creator A5042686399 @default.
• W937952246 creator A5046532778 @default.
• W937952246 creator A5055434353 @default.
• W937952246 creator A5073948389 @default.
• W937952246 creator A5082566702 @default.
• W937952246 date "2015-11-01" @default.
• W937952246 modified "2023-09-27" @default.
• W937952246 title "Caracterização de pacientes com artrite reumatoide quanto a fatores de risco para doenças vasculares cardíacas no Mato Grosso do Sul" @default.
• W937952246 cites W1597643670 @default.
• W937952246 cites W1968962481 @default.
• W937952246 cites W1975503977 @default.
• W937952246 cites W1976091401 @default.
• W937952246 cites W1976525661 @default.
• W937952246 cites W1998623949 @default.
• W937952246 cites W2003309746 @default.
• W937952246 cites W2006724319 @default.
• W937952246 cites W2011132669 @default.
• W937952246 cites W2017161033 @default.
• W937952246 cites W2019832147 @default.
• W937952246 cites W2032604317 @default.
• W937952246 cites W2034746193 @default.
• W937952246 cites W2053009248 @default.
• W937952246 cites W2053556325 @default.
• W937952246 cites W2088081419 @default.
• W937952246 cites W2103706975 @default.
• W937952246 cites W2104015732 @default.
• W937952246 cites W2106802599 @default.
• W937952246 cites W2107455763 @default.
• W937952246 cites W2108006070 @default.
• W937952246 cites W2110826367 @default.
• W937952246 cites W2123684439 @default.
• W937952246 cites W2126273105 @default.
• W937952246 cites W2131071909 @default.
• W937952246 cites W2131120529 @default.
• W937952246 cites W2131872753 @default.
• W937952246 cites W2141146473 @default.
• W937952246 cites W2143417401 @default.
• W937952246 cites W2152348310 @default.
• W937952246 cites W2154328115 @default.
• W937952246 cites W2164623546 @default.
• W937952246 cites W2165724007 @default.
• W937952246 cites W2166396149 @default.
• W937952246 cites W2172201422 @default.
• W937952246 cites W2414476426 @default.
• W937952246 doi "https://doi.org/10.1016/j.rbr.2015.02.001" @default.
• W937952246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26362702" @default.
• W937952246 hasPublicationYear "2015" @default.
• W937952246 type Work @default.
• W937952246 sameAs 937952246 @default.
• W937952246 citedByCount "3" @default.
• W937952246 countsByYear W9379522462018 @default.
• W937952246 countsByYear W9379522462019 @default.
• W937952246 countsByYear W9379522462023 @default.
• W937952246 crossrefType "journal-article" @default.
• W937952246 hasAuthorship W937952246A5042686399 @default.
• W937952246 hasAuthorship W937952246A5046532778 @default.
• W937952246 hasAuthorship W937952246A5055434353 @default.
• W937952246 hasAuthorship W937952246A5073948389 @default.
• W937952246 hasAuthorship W937952246A5082566702 @default.
• W937952246 hasBestOaLocation W9379522461 @default.
• W937952246 hasConcept C126322002 @default.
• W937952246 hasConcept C2777575956 @default.
• W937952246 hasConcept C29456083 @default.
• W937952246 hasConcept C71924100 @default.
• W937952246 hasConceptScore W937952246C126322002 @default.
• W937952246 hasConceptScore W937952246C2777575956 @default.
• W937952246 hasConceptScore W937952246C29456083 @default.
• W937952246 hasConceptScore W937952246C71924100 @default.
• W937952246 hasIssue "6" @default.
• W937952246 hasLocation W9379522461 @default.
• W937952246 hasLocation W9379522462 @default.
• W937952246 hasLocation W9379522463 @default.
• W937952246 hasOpenAccess W937952246 @default.
• W937952246 hasPrimaryLocation W9379522461 @default.
• W937952246 hasRelatedWork W2041279917 @default.
• W937952246 hasRelatedWork W2082406232 @default.
• W937952246 hasRelatedWork W2156283049 @default.
• W937952246 hasRelatedWork W2316954211 @default.
• W937952246 hasRelatedWork W2326094713 @default.
• W937952246 hasRelatedWork W2427075784 @default.
• W937952246 hasRelatedWork W2427452099 @default.
• W937952246 hasRelatedWork W2617939361 @default.
• W937952246 hasRelatedWork W2761967325 @default.
• W937952246 hasRelatedWork W4245782456 @default.
• W937952246 hasVolume "55" @default.
• W937952246 isParatext "false" @default.
• W937952246 isRetracted "false" @default.
• W937952246 magId "937952246" @default.
• W937952246 workType "article" @default.